About Dr. Perry Mansfield, MD., FRCS(C)
Otolaryngology, Head and Neck Surgery/Skull Base Surgery
His mission: To inspire hope, expand the health and well-being of each patient with head and neck/skull base disease, by providing personalized optimal care through integrated clinical practice, and research.
- Director: Skull Base Surgery and Head and Neck Oncology - Senta Clinic
- Fellowship Director - Senta Clinic
- Chairman: Steven Prewitt Skull Base Foundation
- President: Amerisleep Diagnostics Inc.
- President: MSAI Inc.
- US News and World Report: Top Doctors in America: 7 years
- Castle Connolly: Top Doctors of America: 10 years
- San Diego Magazine: Top Doctors: 15 years
- Doctors Across America: Americas Top Doctors: 18 years
- Center for Study of Services Consumer's Handbook: American's Top-Rated Physician in Otolaryngology Head and Neck Surgery: 19 years
Perry T. Mansfield MD., has focused his journey on excellence in patient care. He has been Chairman of four major Head and Neck surgery/Skull base surgery programs, Chaired CME accredited regional Head and Neck /Skull Base surgery rounds for 19 years, presented and published numerous peer reviewed articles, most recently on a series of 3754 continuous tumor cases, has directed International and National Fellowship training programs, was awarded the Canada Bravery award from the Queen of England, participated on the Business Advisory Council to the U.S. Congress, participated on 16 medical staff peer review committees, acted as Chief of Surgery twice and Chief of the Medical Staff, holds several US and International patents, sits on several philanthropic and corporate boards, has co-founded a biotech company, co-founded Senta Clinic, co-founded a hearing healthcare company, founded the largest full-service sleep lab in the region, and founded a healthcare and business management company that serves the southern California region in a wide array of healthcare and business practices.
Perry T. Mansfield, M.D., was born in Toronto, Canada. He obtained a medical school degree with honors and Dean’s List designation from the University of Toronto in 1987. He completed residency/research training, at the University of Toronto in Otolaryngology, Head and Neck Surgery in 1993, as well as Clinical and Research Fellowship in Plastic and Reconstructive surgery at the University of Toronto. As part of his training he spent a year of General/Trauma Surgery in South Central Los Angeles at Harbor UCLA Medical Center and USC Medical Center. During his year in Los Angeles he obtained a California medical License in 1990. He obtained board certifications in both Canada and the United States. He has been a fellow of the Royal College of Physicians and Surgeons and a Diplomat of the American Board of Otolaryngology for over 2 decades. While in Canada, he received the Canadian Humane Association; Canada Award of Bravery (from the Queen of England). “To recognize such deeds of heroism, by Canadians in civilian life…”.
He moved to San Diego in 1993 and opened a small private surgical practice where he joined R. Stuart Weeks MD. His mother’s personal battle with stage 4 lung cancer and untimely death defined his career interest. He worked to develop a focused tertiary referral head and neck cancer practice and within a few years was appointed the Program Medical Director of The Center for Skull Base Surgery a joint program between University of California San Diego and Alvarado Hospital Medical Center. He directed this program for several years creating one of the first dedicated multidisciplinary Skull Base programs in the country. He worked on new intake and data tracking methods for patients with skull base diseases. His progressive approaches changed clinical outpatient and hospital data tracking of disease specific metrics including length of stay and complication measures.
His continued quest to deliver optimal patient satisfaction and patient centered care in the skull base led Dr. Mansfield to co-found Senta Clinic. His mission: To inspire hope, expand the health and well-being of each patient with skull base disease, by providing personalized optimal care through integrated clinical practice, and research. As Founding CEO in 2004, and current board member of Senta Clinic, he worked with patients, business leaders, hospital administrators, healthcare regulatory attorneys, and politicians to help build and grow the various disciplines and ancillary services to support a regional referral skull base program. Senta Clinic provides regional emergency and trauma care to Sharp Healthcare, Prime Healthcare and four Scripps hospitals. Senta Clinic provides all the Neurotrauma support for all patients for all four Scripps hospitals in San Diego county. Senta Clinic in honored to participate in Neurosurgical Military training to assure the Navy Neurosurgeons are combat ready prior to deployment. Senta Clinic is responsible for over 5000 inpatient surgeries, and approximately 50,000 outpatient visits. Senta Clinic has evolved into a digitally integrated healthcare model aggressively interacting with hospital data portals, insurance and government agencies to assure best practice methods, with an emphasis on cost and complication optimization, and length of stay minimization. Dr. Mansfield is the Director of Head and Neck Oncology and Skull base surgery and Fellowship Director at Senta Clinic. His role as a head and neck surgeon focuses on disorders of the skull base specializing in major open and endoscopic tumor ablation and reconstructive approaches. He recently contributed to a textbook with his International Fellow, Dr. Hector Prado: Practice of Otolaryngology, Head and Neck Surgery.
He has published extensively and recently was on the scientific committee and organizing committee of the North American Skull Base Society International meeting attended by over 800 International head and neck cancer and skull base surgeons. In addition, he presented expert didactic lectures in Open skull base surgery and reconstruction, Sino-nasal Melanoma, Economic impact of skull base surgery, Invasive fungal infections in the skull base. Recent publications include: (1) Evaluating the Clinical, Medicolegal, and Economic Impact of Continuous Tracking of Multidisciplinary Skull Base Conference Disease and Patient Metrics. (2) Identifying and Evaluating the Impact and Implications of Collaborative Multidisciplinary Care in Skull Base Treatment: Retrospective Analysis and Literary review- 3224 total cases. (3) The Evolving Role of Immunotherapy in Late-Stage Sino nasal Melanoma. (1) 12-Year Retrospective Analysis of 2,993 Consecutive Skull Base cases. (4) Effect of Continuous Left Ventricular Assist Device Blood Flow in a Free Flap.
In 1995, Dr. Mansfield developed the first regional multisystem Skull Base Surgery and Head and Neck Prospective Multidisciplinary tumor conference. For two decades Dr. Mansfield has presented several thousand cases in collaboration with the specialties of Neurosurgery, head and neck surgery, Oral and Maxillofacial surgery, neuroradiology, radiation oncology, medical oncology, prosthodontists, oculoplastic surgery, neuro-ophthalmology and the rehabilitative disciplines.
In the mid 2000’s, Dr. Mansfield was elected by over 600 physicians to become Chief of Staff, and Chief of Surgery of Alvarado Hospital Medical Center, a 306-bed acute care hospital adjacent to San Diego State University. In addition to the duties of Chief of Staff, he focused on data tracking methods to educate and standardize physician patient care delivery as well as the implementation of the national “Patient safety and Quality Improvement act” of 2005. He participated in the Judicial Review system.
Dr. Mansfield became the Medical Director of Head and Neck Services at Sharp Memorial Hospital in 2014. Sharp HealthCare includes four acute-care hospitals, two affiliated medical groups and a health plan. Sharp operates 2,100 beds, has approximately 2,600 physicians on medical staffs, more than 1,000 physicians in affiliated medical groups and more than 16,000 employees. Dr. Mansfield has worked on implementing best practice methods, standardized nursing protocols, ongoing nursing educational sessions, and skull base training. He has worked to develop a prospective method of multidisciplinary patient care with data tracking metrics to assure optimal acute and long-term care disease management. He was involved in a National campaign to raise awareness of head and Neck cancer and participated as the lead surgeon for a Sharp experience show that has aired Nationally.
Dr. Mansfield has served as Chairman of the Steven Prewitt Skull Base Disease Foundation since its inception in 2005. The Prewitt Foundation is a private charity focusing on the education, treatment and cure of skull base disease.
Dr. Mansfield has been repeatedly selected by US News and World report, Castle-Connelly, Consumer Research Council, Doctor’s across America, and San Diego Magazine by his peers as a top-rated Head and Neck surgeon. He has repeatedly been named to these lists each year for nearly two decades.
He has participated on numerous corporate and philanthropic boards including the USO - San Diego, the San Diego Air and Space Museum, the Polinsky Child Abuse Center. He is the Chairman of the Steven Prewitt Skull Base Disease Foundation.
Dr. Mansfield’s future clinical directions include creation of a Hospital based Center of Excellence Program in Head and Neck Oncology, evolving disease specific care delivery integrated pathways, refine disease specific data portals to optimize resources for care delivery and the creation of contracted disease specific treatment with insurers, government and private industry. His research direction is currently focused on the evolution of technology, IRB protocols and data analysis of novel patented technology.
Dr. Mansfield maintains staff privileges at Scripps Memorial Hospital, Sharp Memorial Hospital, and Sharp Grossmont hospital. He has maintained the highest standing in all the hospitals at which he holds privileges and has extensive peer review experience on various medical staffs, serving on over 15 peer review committees.